cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma

Detalles Bibliográficos
Autores principales: He, Qiong, Zhu, Xian, Shi, Xun, Lin, Chen, Jin, Yin, Yan, Junrong, He, Jiachen, Yu, Xinmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354132/
https://www.ncbi.nlm.nih.gov/pubmed/32676342
http://dx.doi.org/10.21037/tlcr-20-442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354132/
https://www.ncbi.nlm.nih.gov/pubmed/32676342
http://dx.doi.org/10.21037/tlcr-20-442

Ejemplares similares